Evaluation of the efficacy of saccharomyces boulardii in children with acute diarrhea

Medical Forum Monthly

Volumn 22, Issue 6, 2011, Pages 36-39

  Kumar, Suresh ^a   Siyal, Ali Akbar ^a   Brohi, Ali Raza ^a  

^a People s University of Medical and Health Sciences for Women   (Pakistan)

Author keywords

Acute diarrhea; Efficacy; Saccharomyces boulardii

Indexed keywords

ANTIDIARRHEAL AGENT; FUNGUS VACCINE; ORAL REHYDRATION SOLUTION;

ABSENCE OF SIDE EFFECTS; ACUTE DIARRHEA; ANALYTIC METHOD; ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; FECES ANALYSIS; FEVER; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALNUTRITION; NONHUMAN; OBSERVATIONAL STUDY; ORAL REHYDRATION THERAPY; PRESCHOOL CHILD; SACCHAROMYCES BOULARDII; SCHOOL CHILD;

EID: 84860408948     PISSN: 1029385X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Probiotics-Friendly bacteria with host of benefit. World Medical News Oct 2009; 19(8):1-14.
2. Lemberg DA, Ooi CY, Day AS. Probiotics in paediatric gastrointestinal diseases. J Paediatr Child Health 2007; 43:331-6.
3. Rodrigues AC, Nardi RM, Bambirra EA, Vieira EC, Nicoli JR. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. J Appl Bacteriol 1996; 81: 251-6.
4. Czerucka D, Rampai P. Effect of Saccharomyces boulardii on cAMP- and Ca2+-dependent Cl-secretion in T84 cells. Dig Dis Sci 1999; 44: 2359-68.
5. Czerucka D, Dahan S, Mograbi B, Rossi B, Rampai P. Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection. Infect Immun 2001; 69: 1298-305. (Pubitemid 32187573)
6. Pothoulakis C, Kelly CP, Joshi MA, et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993; 104: 1108-15. (Pubitemid 23090764)
7. Brandao RL, Castro IM, Bambirra EA, et al. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol 1998; 64: 564-8 (Pubitemid 28079822)
8. Buts JP, Bernasconi P, Vaerman JP, Dive C. Stimulation of secretory IgA and secretory component of immunoglobulin in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci 1990; 35: 251.
9. Sougioultzis S, Simeonidis S, Bhaskar KR, et al. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 2006; 343: 69-76.
10. Htwe K, Yee KS, Tin M, et al. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study. Am J Trop Med Hyg 2008; 78:214-6. (Pubitemid 351844552)
11. Kurugol Z, Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhea. Acta Paediatr 2005; 94: 44-7. (Pubitemid 40127932)
12. Hafeez A, Tariq P, Ali S, Kundi ZU, Khan A, Hassan M. Efficacy of Saccharomyces Boulardii treatment of acute watery diarrhea in children: A Multi-centre randomized controlled study. J Coll Physicians Surg Pak. Jul 2002; 12(7):423-4.
13. Surawicz CM, Elmer GW, Specimen P, McFarland LV, Chinn J, Van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981-8.
14. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. J Pediatr Gastroenterol Nutr, 1993; 16: 419-25. (Pubitemid 23143772)
15. Castaneda GC, Garcia BE, Santa CDM, Fernandez GM, Monterrey GP.Effects of Saccharomyces boulardii in children with chronic diarrhea, especially cases of giardiasis. Rev Mex Puericultura Pediatria 1995; 2: 12.
16. Besirbellioglu BA, Ulcay A, Can M, Erdem H, Tanyuksel M, Avci IY, Araz E, Pahsa A. Saccharomyces boulardii and infection due to Giardia lamblia. Scand J Infect Dis 2006; 38: 479-81. (Pubitemid 44150785)
17. Mansour-GF, Dehbashi N, Yazdanparast K, Shafaghi A. Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World J Gastroenterol 2003; 9: 1832-3. (Pubitemid 37038141)
18. Kollaritsch H, Hoist H, Grobara P, Wiedermann G. Prevention of travelers' diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study. Fortsschr Med 1993; 111: 152-6.
19. Bleichner G, Blehaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. Intensive Care Med 1997; 23: 517-23.
20. Saint-Marc T, Blehaut H, Musial C, Touraine JL, AIDS-related diarrhea: a double blind trial of Saccharomyces boulardii. Sem Hop 1995; 71: 735-41.
21. Cetina-SG, Sierra BG. Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Ann Pediatr (Paris) 1994; 41: 397-400.
22. Kurugol Z, Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 2005; 94: 44-7. (Pubitemid 40127932)
23. Billoo AG, Memon MA, Khaskheli SA, Murtaza G, Iqbal K, Saeed Shekhani M, Siddiqi AQ. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J Gastroenterol 2006; 12: 4557-60. (Pubitemid 44256346)
24. Villarruel G, Rubio DM, Lopez F, Cintioni J, Gurevech R, Romero G, Vandenplas Y. Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study. Acta Paediatr 2007; 96: 538-41. (Pubitemid 46466118)
25. Hochter W, Chase D, Hagenhoff G. Saccharomyces boulardii in treatment of acute adult diarrhea. Efficacy and tolerance of treatment. Munch Med Wochenschr 1990; 132: 188-92. (Pubitemid 20133037)
26. Urganci N, Polat T, Uysalol M, Çetinkaya F. Evaluation of the efficacy of Saccharomyces boulardii in children with acute diarrhea. Arch Gastroenterohepatol 2001; 20 (3-4): 52-6